Targeting Epstein-Barr virus to treat MS
- PMID: 35590190
- DOI: 10.1016/j.medj.2022.02.005
Targeting Epstein-Barr virus to treat MS
Abstract
Epstein-Barr virus (EBV) is a putative trigger for multiple sclerosis (MS). Bjornevik et al. utilized longitudinal analysis of 10 million adults to strongly link MS to EBV infection1 and Lanz et al. identified clonally expanded B cells in MS that bind EBV EBNA1 and GlialCam.2.
Copyright © 2022. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.Nature. 2022 Mar;603(7900):321-327. doi: 10.1038/s41586-022-04432-7. Epub 2022 Jan 24. Nature. 2022. PMID: 35073561 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
